SCHEMBL15042940

SCHEMBL15042940

CC(C)c1cc2ccc3c(C(C)C)n[nH]c3c2s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15042938 0.75 TLR8 (0.38)
SCHEMBL17791519 0.73 ALOX5 (0.35)
SCHEMBL15042931 0.71 EIF4A3 (0.38)
SCHEMBL15042937 0.71 KIF11 (0.36)
SCHEMBL4548302 0.70 KIF11 (0.41)
SCHEMBL13560732 0.69
SCHEMBL13561517 0.69 KDM4E (0.31)
SCHEMBL12294498 0.69 KDM4E (0.40)
SCHEMBL15042939 0.69 TLR8 (0.35)
SCHEMBL4548299 0.69 MAP3K11 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796705-B2 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases MERCK SHARP & DOHME CORP. (US) 2017-10-24 US disclosed
US-9796705-B2 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases MERCK SHARP & DOHME CORP. (US) 2017-10-24 US disclosed
US-20170008879-A1 FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2017-01-12 US disclosed
US-20130156731-A1 FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEAS SCHERING CORPORATION 2013-06-20 US disclosed